- Potential benefitMay reduce inappropriate denials and improve beneficiary access to medically necessary services by creating a strong fi…
- Potential benefitCould shorten delays in care and lower the burden on beneficiaries by deterring excessive or unjustified prior-authoriz…
- Potential benefitCreates a regulatory deterrent that may force Medicare Advantage organizations to strengthen internal review processes…
To amend title XVIII of the Social Security Act to establish certain requirements with respect to rates of reversed prior authorization coverage determinations under Medicare Advantage plans.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
This bill amends Medicare Advantage rules to set limits on how often prior authorization denials are later reversed. For plan years beginning one year after enactment, if a Medicare Advantage plan has more than 25% of its prior authorization decisions initially deny coverage and are later reversed on reconsideration or appeal, the Secretary must terminate the contract for that plan.
Severity of penalty: liberals view termination as a strong enforcement tool for beneficiaries; centrists and conservatives see termination as too blunt and risky.
Relative to its intended legislative type, this bill establishes a specific substantive standard (a >25% reversal threshold and an additional prong regarding reductions in reconsideration reversals) and prescribes a direct enforcement mechanism (contract termination), but it provides only limited implementation scaffolding, no fiscal acknowledgement, and minimal protections or procedures for measurement and appeal.
This bill amends Medicare Advantage rules to set limits on how often prior authorization denials are later reversed.
For plan years beginning one year after enactment, if a Medicare Advantage plan has more than 25% of its prior authorization decisions initially deny coverage and are later reversed on reconsideration or appeal, the Secretary must terminate the contract for that plan.
The bill also allows the Secretary to find a plan out of compliance if there is a substantial drop in reconsideration reversals compared with the prior year and that drop is due to the plan failing to appropriately reconsider denials.
On content alone, the bill is a narrowly focused, administratively executable change aimed at a recognized policy problem (prior-authorization reversals), which is a point in its favor. However, the unusually punitive enforcement (contract termination) with no intermediate remedies, likely strong industry pushback, absence of compromise provisions, and uncertain fiscal/market impacts make it unlikely to clear both chambers and reach enactment without substantial amendment or being folded into a larger negotiated bill.
Relative to its intended legislative type, this bill establishes a specific substantive standard (a >25% reversal threshold and an additional prong regarding reductions in reconsideration reversals) and prescribes a direct enforcement mechanism (contract termination), but it provides only limited implementation scaffolding, no fiscal acknowledgement, and minimal protections or procedures for measurement and appeal.
Severity of penalty: liberals view termination as a strong enforcement tool for beneficiaries; centrists and conservatives see termination as too blunt and risky.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenThe mandatory-contract-termination penalty could lead some plans to exit markets or narrow plan offerings, reducing ben…
- Potential burdenPlans may respond by raising premiums, reducing supplemental benefits, narrowing provider networks, or avoiding offerin…
- Potential burdenThe rule could increase administrative and compliance costs for MA organizations and for CMS (monitoring, data collecti…
Why the argument around this bill splits.
Severity of penalty: liberals view termination as a strong enforcement tool for beneficiaries; centrists and conservatives see termination as too blunt and risky.
A mainstream liberal observer would likely view this bill as a pro-consumer accountability measure that deters Medicare Advantage plans from improperly denying care via prior authorization.
They would appreciate the explicit trigger based on reversal rates because it ties enforcement to measurable outcomes and could reduce administrative burdens on patients and providers.
However, they would also be attentive to implementation details to ensure the rule protects beneficiaries without creating loopholes that let plans game the metric.
A centrist observer would generally welcome measures that hold Medicare Advantage plans accountable for inappropriate denials, but would be cautious about an immediate contract-termination remedy tied to a single percentage threshold.
They would see the policy intent—reducing inappropriate denials and appeals—as sound, but worry about unintended market disruption, measurement error, and procedural fairness.
Centrists would favor measured implementation with safeguards, data transparency, and opportunities for plans to correct behavior before losing contracts.
A mainstream conservative observer would be skeptical of this bill as an example of federal micromanagement of private plan medical-management practices and a threat to plan flexibility.
They would be concerned that the statute imposes a punitive, automatic termination requirement based on a single percentage threshold, which could destabilize Medicare Advantage markets, reduce plan participation, and raise costs.
They would also worry about vague enforcement and legal exposure for plans and advocate for protections against overbroad federal intervention.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill is a narrowly focused, administratively executable change aimed at a recognized policy problem (prior-authorization reversals), which is a point in its favor. However, the unusually punitive enforcement (contract termination) with no intermediate remedies, likely strong industry pushback, absence of compromise provisions, and uncertain fiscal/market impacts make it unlikely to clear both chambers and reach enactment without substantial amendment or being folded into a larger negotiated bill.
- No cost or budgetary estimate (CBO score) included in the text — the fiscal impact on Medicare spending, premiums, and plan participation is unknown and could affect legislative support.
- How the Secretary would implement and operationalize the metric (data definitions, measurement period, and appeal of CMS termination decisions) is not specified; administrative feasibility could shape support or opposition.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Severity of penalty: liberals view termination as a strong enforcement tool for beneficiaries; centrists and conservatives see termination…
On content alone, the bill is a narrowly focused, administratively executable change aimed at a recognized policy problem (prior-authorizat…
Relative to its intended legislative type, this bill establishes a specific substantive standard (a >25% reversal threshold and an additional prong regarding reductions in reconsideration reversals) and prescribes a dir…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.